PRELUDE CAPITAL MANAGEMENT, LLC - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 60 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$38,000
+8.6%
6,000
+20.0%
0.00%
-33.3%
Q1 2018$35,000
-16.7%
5,000
+25.0%
0.00%0.0%
Q4 2017$42,000
-28.8%
4,000
-38.5%
0.00%
-40.0%
Q3 2017$59,000
-22.4%
6,500
+10.8%
0.01%
-28.6%
Q2 2017$76,000
+18.8%
5,867
+13.5%
0.01%
+16.7%
Q1 2017$64,0005,1670.01%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,142,580$6,442,0002.67%
683 Capital Management, LLC 1,766,038$3,620,0000.33%
BIEGEL & WALLER LLC 66,508$136,0000.07%
Motley Fool Asset Management LLC 176,874$363,0000.04%
Aveo Capital Partners, LLC 16,732$35,0000.02%
ATLAS CAPITAL ADVISORS LLC 12,891$26,426,0000.01%
Paloma Partners Management Co 116,700$239,0000.00%
MILLENNIUM MANAGEMENT LLC 594,956$1,220,0000.00%
A.R.T. Advisors, LLC 13,703$28,0000.00%
Tower Research Capital LLC (TRC) 10,682$22,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders